Phospholipid Metabolites in Recurrent Glioblastoma: In Vivo Markers Detect Different Tumor Phenotypes before and under Antiangiogenic Therapy

Open Access

Peer-reviewed

Research Article

Elke Hattingen ,

* E-mail: elke.hattingen@kgu.de

Affiliation Institute of Neuroradiology, Goethe-University Hospital Frankfurt, Frankfurt, Germany
⨯
Oliver Bähr,

Affiliation Dr. Senckenberg Institute of Neurooncology, Goethe-University Hospital Frankfurt, Frankfurt, Germany
⨯
Johannes Rieger,

Affiliation Dr. Senckenberg Institute of Neurooncology, Goethe-University Hospital Frankfurt, Frankfurt, Germany
⨯
Stella Blasel,

Affiliation Institute of Neuroradiology, Goethe-University Hospital Frankfurt, Frankfurt, Germany
⨯
Joachim Steinbach,

Affiliation Dr. Senckenberg Institute of Neurooncology, Goethe-University Hospital Frankfurt, Frankfurt, Germany
⨯
Ulrich Pilatus

Affiliation Institute of Neuroradiology, Goethe-University Hospital Frankfurt, Frankfurt, Germany
⨯

Reader Comments (0)

Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Malignant tumors
Is the Subject Area "Malignant tumors" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Metabolites
Is the Subject Area "Metabolites" applicable to this article?

Thanks for your feedback.
Membrane metabolism
Is the Subject Area "Membrane metabolism" applicable to this article?

Thanks for your feedback.
Lipid metabolism
Is the Subject Area "Lipid metabolism" applicable to this article?

Thanks for your feedback.
Energy metabolism
Is the Subject Area "Energy metabolism" applicable to this article?

Thanks for your feedback.
Magnetic resonance imaging
Is the Subject Area "Magnetic resonance imaging" applicable to this article?

Thanks for your feedback.